Compartment-specific skeletal involvement in systemic sclerosis characterized by peripheral QCT and serum osteoimmune mediators: a case-control study
Calcified Tissue International · 2026
DOI: 10.1007/s00223-026-01624-5 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Calcified Tissue International, 2026. Verfasst von Dóra Csige und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Móricz Zsigmond út 22, Debrecen, 4032, Hungar…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Bone and Bones. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union grant, Ministry for Culture and Innovation (Hungary) from the source of the National Research Development and Innovation Fund, Count István Tisza Foundation for the University of Debrecen.
Abstract (Originalsprache)
Systemic sclerosis (SSc) is associated with increased bone fragility, yet early, compartment-specific alterations and their osteoimmunological correlates remain incompletely characterized. This study aimed to assess bone status in SSc using dual X-ray absorptiometry (DXA) complemented by peripheral quantitative computed tomography (pQCT), and to evaluate their associations with a targeted osteoimmunological biomarker panel and clinical risk scores. This prospective cross-sectional study included 40 women with SSc (disease duration ≤ 7 years from diagnosis) and 45 non-immune female controls, frequency-matched by age. Bone status was assessed by DXA (lumbar spine, femoral neck) and distal radius pQCT. Serum levels of routine bone and mineral metabolism markers, alongside a targeted panel of osteoimmunological mediators (OPG, OPN, PDGF-BB, ACP5, RANKL, TNF-α, IL-6, IL-1β, DKK-1) using multiplex immunoassay were measured. FRAX scores were calculated to contextualize clinical fracture risk. With broadly comparable DXA-defined bone status, pQCT revealed significantly lower trabecular volumetric bone mineral density (vBMD) in SSc, while total and cortical+subcortical vBMD were comparable. Routine biochemical markers showed substantial overlap between groups, whereas SSc patients exhibited a distinct osteoimmune profile with significantly elevated OPG, ACP5, RANKL, PDGF-BB, IL-6, IL-1β, DKK-1, and RANKL/OPG after FDR correction. Exploratory biomarker–bone associations did not remain significant after correction for multiple testing. In women with relatively early SSc, pQCT identified compartment-specific differences, particularly within the trabecular compartment, despite comparable DXA-defined bone status. A distinct osteoimmunological biomarker profile was also observed in SSc, providing complementary information on disease-related skeletal alterations, while specific biomarker–bone associations require further confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Móricz Zsigmond út 22, Debrecen, 4032, Hungary. csige.dora@med.unideb.hu.
- Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary. csige.dora@med.unideb.hu.
- Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Móricz Zsigmond út 22, Debrecen, 4032, Hungary.
- Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary.
Förderung
- European Union grant
- Ministry for Culture and Innovation (Hungary) from the source of the National Research Development and Innovation Fund
- Count István Tisza Foundation for the University of Debrecen
Zitieren
APA
Csige, D., Horváth, Á., Bodoki, M., Rebenku, I., Lipták-Lukácsik, S., Pomázi, L. R., Pethő, Z., Mogyoróssy, S., Hamar, A., Bodnár, N., Falcsik, R., Hodosi, K., Panyi, G., Szamosi, S., Szekanecz, Z., Szűcs, G., Végh, E., & Bodoki, L. (2026). Compartment-specific skeletal involvement in systemic sclerosis characterized by peripheral QCT and serum osteoimmune mediators: a case-control study. Calcified Tissue International. https://doi.org/10.1007/s00223-026-01624-5
Vancouver
Csige D, Horváth Á, Bodoki M, Rebenku I, Lipták-Lukácsik S, Pomázi LR, et al. Compartment-specific skeletal involvement in systemic sclerosis characterized by peripheral QCT and serum osteoimmune mediators: a case-control study. Calcified Tissue International. 2026. doi:10.1007/s00223-026-01624-5
BibTeX
@article{Csige2026,
author = {Csige, Dóra and Horváth, Ágnes and Bodoki, Monika and Rebenku, István and Lipták-Lukácsik, Sára and Pomázi, Lilla Ramóna and Pethő, Zsófia and Mogyoróssy, Sándor and Hamar, Attila and Bodnár, Nóra and Falcsik, Rebeka and Hodosi, Katalin and Panyi, György and Szamosi, Szilvia and Szekanecz, Zoltán and Szűcs, Gabriella and Végh, Edit and Bodoki, Levente},
title = {Compartment-specific skeletal involvement in systemic sclerosis characterized by peripheral QCT and serum osteoimmune mediators: a case-control study},
journal = {Calcified Tissue International},
year = {2026},
doi = {10.1007/s00223-026-01624-5}
}
EUVIMED